BG Medicine Files 510(k) for Automated Galectin-3 Test on Abbot Architect Platform
July 27, 2012
BG Medicine Files 510(k) for Automated Galectin-3 Test on Abbot Architect Platform
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BG Medicine Q1 Revenues Fall but Galectin-3 Sales Jump as Company Pursues Expanded Use for Test
May 17, 2012 / ProteoMonitor - Lower CMS Payment Rate Could Affect Royalties, BG Medicine Says
March 26, 2013 / GenomeWeb Daily News - BG Medicine Partners with Siemens on Automated Version of Galectin-3 Heart Failure Prognostic
January 7, 2011 / ProteoMonitor - BG Medicine Posts 85 Percent Jump in Q1 Revenues, Appoints New CEO
May 10, 2013 / ProteoMonitor - Abbott Receives EU CE Mark for Automated Version of BG Medicine's Galectin-3 Test
April 12, 2013 / ProteoMonitor